Indications

Treatment of B-cell chronic lymphocytic leukemia in patients who have been treated with alkylating agents and in which fludarabine therapy has failed

alemtuzumab is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other Davis's Drug Guide topics, please login or purchase a subscription.